51. 口服补液盐联合米多君对小儿血管迷走性晕厥的疗效 及血清电解质水平、Cor 和 BNP 表达水平的影响.
- Author
-
梁妍琰, 张国栋, 苏学文, 卢晓颖, and 朱 华
- Subjects
- *
BRAIN natriuretic factor , *HEALTH education , *INTEREST rates , *RESEARCH teams , *SYNCOPE - Abstract
Objective: To investigate the effect of oral rehydration salts (ORS) combined with midodrine on serum electrolyte, expression levels of cortisol (Cor) and brain natriuretic peptide (BNP) in the treatment of vasovagal syncope (VVS). 90 VVS children admitted to department of pediatrics of our hospital from February 2019 to January 2021 were randomly divided into the matched group and research group, each group has 45 cases. Both groups were accepted with health education, the matched group was treated with midodrine, the research group was treated with midodrine combined with ORS. The clinical efficacy, negative rates, recurrence rates, HR and SBP, serum electrolyte levels, expression levels of Cor and BNP were combined, the adverse reactions during the research were recorded. The total effective rate of research group was higher than matched group (P<0.05). The negative rates of research group was higher than matched group, and the recurrence rate was lower than that in the control group (P<0.05). The HR and SBP of two group before and after the treatment had no difference (P>0.05). The levels of serum sodium, calcium and chlorine of two groups after treatment were all increased, while phosphorus, potassium were decreased (P<0.05); as compared with matched group, the levels of serum sodium, calcium and chlorine of research group after treatment were higher, while phosphorus, potassium were lower(P<0.05). The expression levels of serum Cor and BNP of two groups after treatment were all decreased(P<0.05); as compared with matched group, the expression levels of serum Cor and BNP of research group after treatment were lower (P<0.05). There was no difference of incidence of adverse reactions of two groups during the research(P>0.05). ORS combined with midodrine was effective in the treatment of VVS, the serum electrolyte was improved and the expression levels of serum Cor and BNP were decreased without obvious adverse reactions. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF